Emerging Trends in Cancer Therapies (Small Molecule Drugs and Biologicals) (Technical Insights)

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

This research service analyzes the emerging trends in cancer therapies with respect to small molecule drugs and biologicals.

Table of Contents

Emerging Trends in Cancer Therapies (Small Molecule Drugs and Biologicals) (Technical Insights), Executive SummaryScope and MethodologyScope and SegmentationMethodologyIndustry OverviewAn Overview of AntiCancer Therapeutics IndustryKey FindingsEmerging Trends in Cancer Therapies (Small Molecule Drugs and Biologicals) (Technical Insights), Technology Trend and Adoption Factor AnalysisTechnology Trends in Cancer TherapiesEmerging Trends in Anticancer Therapeutic Approaches--Diagnostics; Therapeutics; and Drug DeliveryAnalysis of Potential Opportunities for Cancer ResearchStrategic Analysis and RecommendationsGrowth Accelerating Factors for Anticancer Drug TherapiesGrowth Restraining Factors for Anticancer TherapiesStrategic RecommendationsTechnologies Impacting Future of Cancer TherapyCancer Research Funding SourcesCorporate Mergers and AcquisitionsEmerging Trends in Cancer Therapies (Small Molecule Drugs and Biologicals) (Technical Insights), Global Developments in Cancer TherapiesNoteworthy Developments in Corporate SectorKinase Inhibiting Oral Drug to Treat GIST and Renal Cell CarcinomaVEGF Inhibitor Drug Effectively Treats Metastatic Breast CancerDual Action Heparan Sulphate Mimetic for Hepatocellular CarcinomaUnique Technology with Multiple Applications for Cancer Diagnosis and TherapyNext Generation Small Molecule Drug for Peripheral T-cell LymphomasCancer Killing Virus Technology to Treat Metastatic MelanomaAutomated FISH Technology for Cancer DiagnosisNovel Technology that Overcomes Immune Tolerance to Self Antigens in Cancer and Immunological DiseasesNovel Technology Platform for Discovery of Novel Class of Cancer TherapeuticsGround Breaking Liposomal Drug Delivery Technology for Cancer TherapyDisease Specific Microarray for the Development of Diagnostic and prognostic Tests for CancerNovel Therapy to Treat Malignant GliomaDNA Interference Drug to Treat Cancer and Genetic DiseasesPersonalized Cancer Diagnostic Test Aids the Selection of Chemotherapeutic DrugsNoteworthy Developments in AcademiaDiscovery of Telomerase Related Proteins Raises Hopes of Antitumor TherapyNanoworms Enable Tumor Targeting and Diagnostic Imaging of CancersEmerging Trends in Cancer Therapies (Small Molecule Drugs and Biologicals) (Technical Insights), Intellectual Property Scenario and Key Industry ParticipantsPatent DetailsCorporate SectorAcademic SectorContact DetailsIndustry ParticipantsUniversity and AcademiaEmerging Trends in Cancer Therapies (Small Molecule Drugs and Biologicals) (Technical Insights), Decision Support DatabaseDecision Support TablesNumber of Biotech Companies (2002 to 2012)Venture Capital Investment in Biotechnology (2002 to 2012)Incidence of Breast Cancer (2002 to 2012)Incidence of Prostate Cancer (2002 to 2012)Incidence of Bladder Cancer (2002 to 2012)Incidence of Liver Cancer (2002 to 2012)




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.